Valens Semiconductor Ltd. posted fourth-quarter revenue of $19.4 million, significantly above guidance of $18.2–$18.9 million, marking its seventh consecutive quarter of growth. The figure represents an increase from $17.3 million in the third quarter and $16.7 million in the same period last year. GAAP gross margin was 60.5%, exceeding guidance while easing slightly from 63.0% in the previous quarter. The adjusted EBITDA loss of $4.3 million was within the guided range of $4.6 to $4.2 million.
While momentum remains solid, near-term results are being modestly affected by tariffs in automotive and some foreign exchange pressure. Visibility remains mixed, but steady growth is expected through 2026 as ProAV normalizes, machine vision and medical applications ramp up, and automotive stabilizes with continued A-PHY progress. Support also comes from share repurchases, a $5 million annual operating expense savings plan, and a new automotive win tied to the Chinese market.
Automotive momentum improved with sequential revenue growth, better margins, and a new China-linked design win. The strong balance sheet and 2026 growth outlook help offset near-term tariff, FX, and seasonal automotive headwinds. Stonegate Capital Partners, which provides investor relations and equity research services, updated its coverage on the company. More details are available in the full announcement at https://www.stonegateinc.com.
The company's performance demonstrates resilience in a challenging environment, with consistent revenue growth and margin execution. The focus on key markets like automotive, ProAV, machine vision, and medical applications positions Valens for continued expansion. The new automotive design win in China represents a strategic opportunity in a critical market, while cost-saving initiatives and share repurchases provide additional financial flexibility.
